Coordinated Multicellular Immune Programs and Drug Targets Revealed by Single-Cell Analysis in Driver-Mutated NSCLC
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27093997 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Kuan Yang und 12 weiteren Autor:innen. Beteiligte Einrichtung: College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Mutation, Lung Neoplasms, Single-Cell Analysis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Major Program, National Natural Science Foundation of China, Key Research and Development Program of Heilongjiang Province.
Abstract (Originalsprache)
Oncogenic driver mutations in non-small cell lung cancer (NSCLC) activate defined signaling pathways that sustain tumor growth and influence the immune landscape. Yet, how coordinated interactions among diverse cell populations within the tumor immune microenvironment (TIME) contribute to this process remains largely unresolved. To address this, we profiled approximately 200,000 single cells from 45 treatment-naïve NSCLC patients representing seven major driver mutations. This analysis uncovered five multicellular modules (CM1–5) with distinct functional properties, each linked to specific malignant regulatory programs. Among them, CM2 and CM5 exhibited pronounced invasive features and were associated with unfavorable clinical outcomes. CM2 was predominantly observed in EGFR- and MET-driven brain metastases and was defined by strong crosstalk between astrocytes and myofibroblasts. Factors such as SPP1, PTN, and PSAP, together with metabolic alterations, contributed to a microenvironment supportive of metastatic colonization in the brain. By contrast, CM5 was enriched in ROS1-, KRAS-, and EGFR-mutant tumors and consisted of diverse myeloid and endothelial subsets characterized by immunosuppressive and pro-angiogenic signaling, including MIF, GALECTIN, and RETN, collectively facilitating immune escape and vascular remodeling. We further constructed and validated a driver mutation-specific prognostic signature (DMSP.sig) model integrating receptor–ligand interactions and core transcription factors, which effectively stratified patient survival. Leveraging this model, we also identified potential therapeutic candidates linked to these prognostic features, highlighting opportunities for clinical intervention. In summary, our study delineates how oncogenic drivers give rise to distinct TIME architectures, providing a framework for prognostic assessment and precision immunotherapy in high-risk NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China.
- School of Intelligent Medicine and Technology, Big Data Research Center, Hainan Medical University, No. 3 Xueyuan Road, Longhua District, Haikou 571199, China.
ORCID-Profile: Xing Gao, Jing Bai, Yunpeng Zhang, Xia Li
Förderung
- National Science and Technology Major Program
- National Natural Science Foundation of China
- Key Research and Development Program of Heilongjiang Province
- China Postdoctoral Science Foundation
- Heilongjiang Postdoctoral Fund
- Longjiang New Era Outstanding Doctoral Dissertation Project Grant
- Harbin Medical University
Zitieren
APA
Yang, K., Yang, K., Wang, J., Zhao, H., Jiang, W., Mu, D., Peng, X., Yan, Y., Gao, X., Bai, J., Hu, C., Zhang, Y., & Li, X. (2026). Coordinated Multicellular Immune Programs and Drug Targets Revealed by Single-Cell Analysis in Driver-Mutated NSCLC. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27093997
Vancouver
Yang K, Yang K, Wang J, Zhao H, Jiang W, Mu D, et al. Coordinated Multicellular Immune Programs and Drug Targets Revealed by Single-Cell Analysis in Driver-Mutated NSCLC. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27093997
BibTeX
@article{Yang2026,
author = {Yang, Kuan and Yang, Kaiyue and Wang, Jiasi and Zhao, Hang and Jiang, Wenqi and Mu, Depeng and Peng, Xiao and Yan, Yiming and Gao, Xing and Bai, Jing and Hu, Congxue and Zhang, Yunpeng and Li, Xia},
title = {Coordinated Multicellular Immune Programs and Drug Targets Revealed by Single-Cell Analysis in Driver-Mutated NSCLC},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27093997}
}
EUVIMED